Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation

BioRestorative Therapies, Inc. (BRTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/04/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/15/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/14/2023 8-K Quarterly results
04/14/2023 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]:
04/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Independent Registered Public Accounting Firm’s Consent",
"Independent Registered Public Accounting Firm’s Consent"
04/04/2023 4 Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns: Bought 747 shares @ $3.56, valued at $2.7k
03/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/22/2023 4 Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns: Paid exercise price by delivering 6,729 shares @ $2.92, valued at $19.6k
03/22/2023 4 ALSTODT LANCE (President, CEO, COB) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns: Paid exercise price by delivering 6,729 shares @ $2.92, valued at $19.6k
02/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2023 4 ALSTODT LANCE (President, CEO, COB) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns: Paid exercise price by delivering 374 shares @ $2.99, valued at $1.1k
02/14/2023 SC 13G/A Auctus Fund Management LLC reports a 9.9% stake in BioRestorative Therapies, Inc.
02/13/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
02/07/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
02/07/2023 SC 13G/A Hudson Bay Capital Management LP reports a 0% stake in BioRestorative Therapies, Inc.
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2023 4 ALSTODT LANCE (President, CEO, COB) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns: Bought 200 shares @ $3.01, valued at $602
01/24/2023 4 ALSTODT LANCE (President, CEO, COB) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns: Bought 100 shares @ $3.1, valued at $310
Bought 100 shares @ $3.17, valued at $317
01/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 8-K Quarterly results
12/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy